{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:17:20Z","timestamp":1792441040102,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403937"],"award-info":[{"award-number":["82403937"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373397"],"award-info":[{"award-number":["82373397"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07319-z","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:44:45Z","timestamp":1767055485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["LAPTM5 drives omental metastasis in high-grade serous ovarian cancer via TGF-\u03b2\/Smad-mediated epithelial plasticity"],"prefix":"10.1186","volume":"23","author":[{"given":"Yan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhefeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-1125","authenticated-orcid":false,"given":"Wentao","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"7319_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74:229\u201363.","journal-title":"Cancer J Clin"},{"key":"7319_CR2","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet (London England). 2019;393:1240\u201353.","journal-title":"Lancet (London England)"},{"key":"7319_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","volume":"26","author":"S Pradeep","year":"2014","unstructured":"Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, et al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell. 2014;26:77\u201391.","journal-title":"Cancer Cell"},{"key":"7319_CR4","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1016\/j.cell.2023.07.004","volume":"186","author":"S Chowdhury","year":"2023","unstructured":"Chowdhury S, Kennedy JJ, Ivey RG, Murillo OD, Hosseini N, Song X, et al. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell. 2023;186:3476\u2013e34983435.","journal-title":"Cell"},{"key":"7319_CR5","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43018-023-00599-8","volume":"4","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wang X, Cheng X, Liu Z, Yin Y, Li X, et al. Single-cell analyses implicate Ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. Nat Cancer. 2023;4:1138\u201356.","journal-title":"Nat Cancer"},{"key":"7319_CR6","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","volume":"28","author":"J Xu","year":"2022","unstructured":"Xu J, Fang Y, Chen K, Li S, Tang S, Ren Y, et al. Single-Cell RNA sequencing reveals the tissue architecture in human High-Grade serous ovarian cancer. Clin Cancer Res. 2022;28:3590\u2013602.","journal-title":"Clin Cancer Res"},{"key":"7319_CR7","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-20-0521","volume":"80","author":"L Geistlinger","year":"2020","unstructured":"Geistlinger L, Oh S, Ramos M, Schiffer L, LaRue RS, Henzler CM, et al. Multiomic analysis of subtype evolution and heterogeneity in High-Grade serous ovarian carcinoma. Cancer Res. 2020;80:4335\u201345.","journal-title":"Cancer Res"},{"key":"7319_CR8","doi-asserted-by":"crossref","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3, et al. Comprehensive integration of Single-Cell data. Cell. 2019;177:1888\u2013e190221.","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"7319_CR9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396\u2013401.","journal-title":"Science"},{"key":"7319_CR10","doi-asserted-by":"crossref","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Current protocols in bioinformatics. 2013;43:11.10.11\u201311.10.33.","DOI":"10.1002\/0471250953.bi1110s43"},{"key":"7319_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18:533\u201348.","journal-title":"Nat Rev Cancer"},{"key":"7319_CR12","doi-asserted-by":"publisher","first-page":"eadh5548","DOI":"10.1126\/science.adh5548","volume":"384","author":"AE Whiteley","year":"2024","unstructured":"Whiteley AE, Ma D, Wang L, Yu SY, Yin C, Price TT, et al. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis. Science. 2024;384:eadh5548.","journal-title":"Science"},{"key":"7319_CR13","first-page":"1564","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis Cell. 2023;186:1564\u201379.","journal-title":"Metastasis Cell"},{"key":"7319_CR14","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1038\/s41467-020-18637-9","volume":"11","author":"J Liu","year":"2020","unstructured":"Liu J, Adhav R, Miao K, Su SM, Mo L, Chan UI, et al. Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor. Nat Commun. 2020;11:4875.","journal-title":"Nat Commun"},{"key":"7319_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41586-023-05820-3","volume":"617","author":"A Jbara","year":"2023","unstructured":"Jbara A, Lin KT, Stossel C, Siegfried Z, Shqerat H, Amar-Schwartz A, et al. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. Nature. 2023;617:147\u201353.","journal-title":"Nature"},{"key":"7319_CR16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1053\/j.gastro.2023.07.019","volume":"165","author":"M Zhang","year":"2023","unstructured":"Zhang M, Chen C, Lu Z, Cai Y, Li Y, Zhang F, et al. Genetic control of alternative splicing and its distinct role in colorectal cancer mechanisms. Gastroenterology. 2023;165:1151\u201367.","journal-title":"Gastroenterology"},{"key":"7319_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2024.04.001","volume":"101","author":"YE Zhang","year":"2024","unstructured":"Zhang YE, Stuelten CH. Alternative splicing in EMT and TGF-\u03b2 signaling during cancer progression. Sem Cancer Biol. 2024;101:1\u201311.","journal-title":"Sem Cancer Biol"},{"key":"7319_CR18","doi-asserted-by":"publisher","first-page":"27691","DOI":"10.1074\/jbc.M112.355917","volume":"287","author":"WK Glowacka","year":"2012","unstructured":"Glowacka WK, Alberts P, Ouchida R, Wang JY, Rotin D. LAPTM5 protein is a positive regulator of Proinflammatory signaling pathways in macrophages. J Biol Chem. 2012;287:27691\u2013702.","journal-title":"J Biol Chem"},{"key":"7319_CR19","doi-asserted-by":"publisher","first-page":"e2205629119","DOI":"10.1073\/pnas.2205629119","volume":"119","author":"Y Wang","year":"2022","unstructured":"Wang Y, Liu J, Akatsu C, Zhang R, Zhang H, Zhu H, et al. LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway. Proc Natl Acad Sci U S A. 2022;119:e2205629119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7319_CR20","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1038\/s41467-022-31783-6","volume":"13","author":"B Jiang","year":"2022","unstructured":"Jiang B, Zhao X, Chen W, Diao W, Ding M, Qin H, et al. Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation. Nat Commun. 2022;13:4141.","journal-title":"Nat Commun"},{"key":"7319_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3892\/ijo.2016.3788","volume":"50","author":"L Chen","year":"2017","unstructured":"Chen L, Wang G, Luo Y, Wang Y, Xie C, Jiang W, et al. Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0\/G1 phase of bladder cancer cells. Int J Oncol. 2017;50:263\u201371.","journal-title":"Int J Oncol"},{"key":"7319_CR22","doi-asserted-by":"crossref","unstructured":"Han S, Jin X, Hu T, Chi F. LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt\/\u03b2\u2013catenin pathway. Oncol Rep. 2023;49.","DOI":"10.3892\/or.2023.8497"},{"key":"7319_CR23","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-17-0246","volume":"23","author":"C Wang","year":"2017","unstructured":"Wang C, Armasu SM, Kalli KR, Maurer MJ, Heinzen EP, Keeney GL, et al. Pooled clustering of High-Grade serous ovarian cancer gene expression leads to novel consensus subtypes associated with survival and surgical outcomes. Clin Cancer Res. 2017;23:4077\u201385.","journal-title":"Clin Cancer Res"},{"key":"7319_CR24","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1038\/s41388-021-01760-2","volume":"40","author":"L Xu","year":"2021","unstructured":"Xu L, Liu W, Li T, Hu Y, Wang Y, Huang L, et al. Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-\u03b2\/Smad signaling pathway in lung cancer. Oncogene. 2021;40:3578\u201392.","journal-title":"Oncogene"},{"key":"7319_CR25","doi-asserted-by":"publisher","first-page":"e112806","DOI":"10.15252\/embj.2022112806","volume":"42","author":"C Fan","year":"2023","unstructured":"Fan C, Wang Q, Kuipers TB, Cats D, Iyengar PV, Hagenaars SC, et al. LncRNA LITATS1 suppresses TGF-\u03b2-induced EMT and cancer cell plasticity by potentiating T\u03b2RI degradation. EMBO J. 2023;42:e112806.","journal-title":"EMBO J"},{"key":"7319_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cac2.12130","volume":"41","author":"S Li","year":"2021","unstructured":"Li S, Zhang J, Qian S, Wu X, Sun L, Ling T, et al. S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-\u03b2\/USF2 axis in colorectal cancer. Cancer Commun (London England). 2021;41:154\u201370.","journal-title":"Cancer Commun (London England)"},{"key":"7319_CR27","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Ng AS, Cai S, Li Q, Yang L, Kerr D. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol. 2021;22:e358\u201368.","journal-title":"Lancet Oncol"},{"key":"7319_CR28","doi-asserted-by":"publisher","first-page":"e108647","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40:e108647.","journal-title":"EMBO J"},{"key":"7319_CR29","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1038\/s41388-021-01913-3","volume":"40","author":"Y Li","year":"2021","unstructured":"Li Y, Fei H, Lin Q, Liang F, You Y, Li M, et al. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers. Oncogene. 2021;40:5131\u201341.","journal-title":"Oncogene"},{"key":"7319_CR30","doi-asserted-by":"publisher","first-page":"216437","DOI":"10.1016\/j.canlet.2023.216437","volume":"578","author":"S Dogra","year":"2023","unstructured":"Dogra S, Elayapillai SP, Qu D, Pitts K, Filatenkov A, Houchen CW, et al. Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer. Cancer Lett. 2023;578:216437.","journal-title":"Cancer Lett"},{"key":"7319_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1186\/s12967-025-06650-9","volume":"23","author":"B Rui","year":"2025","unstructured":"Rui B, Yang Y, Geng D, Kuang Z, Mu T, Liu Y, Ren B, et al. LINC02888 promotes HGSOC progression and immune evasion via PPIB-mediated stabilization of LAPTM5 mRNA and Inhibition of RIG-I-like receptor signaling. J Transl Med. 2025;23:640.","journal-title":"J Transl Med"},{"key":"7319_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","volume":"17","author":"SC Bonnal","year":"2020","unstructured":"Bonnal SC, L\u00f3pez-Oreja I, Valc\u00e1rcel J. Roles and mechanisms of alternative splicing in cancer - implications for care. Nat Rev Clin Oncol. 2020;17:457\u201374.","journal-title":"Nat Rev Clin Oncol"},{"key":"7319_CR33","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/cancers14071726","volume":"14","author":"A Bernard","year":"2022","unstructured":"Bernard A, Boidot R, V\u00e9gran F. Alternative splicing in cancer and immune cells. Cancers (Basel). 2022;14:1726.","journal-title":"Cancers (Basel)"},{"key":"7319_CR34","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/15476286.2022.2113148","volume":"19","author":"S Wang","year":"2022","unstructured":"Wang S, Wang S, Zhang X, Meng D, Xia Q, Xie S, et al. Comprehensive analysis of prognosis-related alternative splicing events in ovarian cancer. RNA Biol. 2022;19:1007\u201318.","journal-title":"RNA Biol"},{"key":"7319_CR35","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-03-0439","volume":"10","author":"X He","year":"2004","unstructured":"He X, Ee PL, Coon JS, Beck WT. Alternative splicing of the multidrug resistance protein 1\/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clin Cancer Res. 2004;10:4652\u201360.","journal-title":"Clin Cancer Res"},{"key":"7319_CR36","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1159\/000484458","volume":"43","author":"L Chen","year":"2017","unstructured":"Chen L, Yao Y, Sun L, Zhou J, Miao M, Luo S, et al. Snail driving alternative splicing of CD44 by ESRP1 enhances invasion and migration in epithelial ovarian cancer. Cell Physiol Biochem. 2017;43:2489\u2013504.","journal-title":"Cell Physiol Biochem"},{"key":"7319_CR37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/onc.2010.426","volume":"30","author":"X He","year":"2011","unstructured":"He X, Arslan AD, Pool MD, Ho TT, Darcy KM, Coon JS, et al. Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene. 2011;30:356\u201365.","journal-title":"Oncogene"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07319-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07319-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07319-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:44:46Z","timestamp":1767055486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07319-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7319"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07319-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical specimens were collected from Beijing Obstetrics and Gynecology Hospital. The study protocol was approved by the hospital\u2019s Institutional Ethics Committee (approval number: 2023-KY-080-01) and conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all patients or their families. The animal study was in accordance with the Declaration of Beijing Obstetrics and Gynecology Hospital and approved by the Ethics Committee of Beijing Obstetrics and Gynecology Hospital, Capital Medical University (Approval number BOGH21\u20132306-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the manuscript and provided their consent for the submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1431"}}